Search results

Technologies 1

• Engineered Brain Organoids
  The ability to derive and manipulate pluripotent stem cells has opened up new avenues for modeling biological systems in both healthy and diseased conditions. In order to more fully recapitulate the tissue microenvironment with its cell-cell, cell-extracellular matrix, and cell-niche interactions, it is essential to transition stem-cell culturing from monolayers to 3D structures. Self-organization of...

Collaborations 1

• Brain Targeting Program
  Pre-competitive multi-partner industry collaboration that aims to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain.

News 8

View all

• Community
  
  Reimagine the World
  September 22, 2022
• Community
  
  Ana Raquel Santa Maria on Breaking Through the Blood-Brain Barrier to Treat Brain Disease
  March 17, 2022
• Translation News
  
  Harvard’s Wyss Institute initiates industry partnership to facilitate brain-targeted drug delivery
  June 10, 2021

Multimedia 4

• 

  Video/Animation
  Reimagining Neurodegenerative Disease Treatment for Her Grandfather: Mariana Garcia-Corral
  Mariana Garcia-Corral is a Research Assistant studying brain organoids to help with the treatment of bi-polar disorder. In this video, she shares a poignant personal story about her grandfather suffering from Lewy body dementia and how she would Reimagine a World with better neurodegenerative disease treatment. Credit: Wyss Institute at Harvard University

• 

  Video/Animation
  Reimagine the World: Volume 1
  Four Wyss Institute scientists, Mariana Garcia-Corral, Pawan Jolly, Megan Sperry, and Mike Super, share how they would Reimagine the World and the personal stories that fuel their passion for the work they are doing. We’d love to hear how you would Reimagine the World! Please visit the following link to share your ideas: https://wyss.typeform.com/to/o9xM7cG1 Credit:...

• 

  Video/Animation
  Eliminating brain cancer at its source | Natalie Artzi | TEDxMIT
  Glioblastoma is a lethal, aggressive brain cancer with a dismal median overall survival rate of 15 months, a number that has remained unchanged for decades. Treatment for this devastating disease involves surgical resection followed by chemotherapy and radiation therapy; however, tumor recurrence is inevitable as it is impossible to eliminate all tumor cells with current...

• 

  Video/Animation
  Wyss Institute Brain Targeting Program
  This animation explains how Wyss Institute researchers and their industry partners aim to identify novel transport targets and shuttle compounds to enable more effective delivery of drugs to the brain. Credit: Wyss Institute at Harvard University.